Trial Profile
A phase 2, 12-week randomized, double-blind, placebo-controlled, study to evaluate safety, tolerability, pharmacokinetic and effect on glycemic control of p1736-05 in subjects with type 2 diabetes mellitus
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 31 Aug 2016
Price :
$35
*
At a glance
- Drugs P 1736 (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Piramal Life Sciences
- 19 Feb 2011 New trial record